Kubo Ai, Corley Douglas A
Kaiser Permanente Division of Research, 2000 Broadway, Oakland, CA 94612, USA.
Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):872-8. doi: 10.1158/1055-9965.EPI-05-0860.
The incidence of esophageal adenocarcinoma has increased markedly in recent decades in many countries. Obesity is a potential risk factor, although the results of individual studies differ. We did a systematic review and statistical synthesis of studies that evaluated the association between body mass index (BMI) and the risk of esophageal adenocarcinoma or the adjacent gastric cardia adenocarcinoma.
We identified potential studies using Medline, the Web of Science database, a manual review of the literature and expert bibliographies. Studies were included if they reported (a) a measure of body mass; (b) the occurrence of esophageal or cardia adenocarcinoma diagnosis; and (c) a relative risk or odds ratio (OR) with confidence intervals (CI) or provided sufficient data to permit their calculation.
We identified 14 studies (2 cohort, 12 case-control; 2,488 esophageal and 2,509 cardia adenocarcinomas). A high BMI (>25) was associated with an increased risk of esophageal adenocarcinoma (males, OR, 2.2; 95% CI, 1.7-2.7; females, OR, 2.0; 95% CI, 1.4-2.9). Higher levels of BMI were associated with increased risk (overweight males, OR, 1.8; 95% CI, 1.5-2.2; obese males, OR, 2.4; 95% CI, 1.9-3.2). The overall associations with cardia cancer were heterogeneous, although stratification by study location provided homogeneous results for populations from the United States or Europe. A high BMI was weakly associated with the risk of cardia adenocarcinoma (OR, 1.5; 95% CI, 1.3-1.8; P(heterogeneity) = 0.38).
Pooled results from observational studies support a positive association between high BMI and the risk for esophageal and possibly for cardia adenocarcinoma.
近几十年来,许多国家食管腺癌的发病率显著上升。肥胖是一个潜在的风险因素,尽管个别研究结果存在差异。我们对评估体重指数(BMI)与食管腺癌或邻近贲门腺癌风险之间关联的研究进行了系统评价和统计分析。
我们通过医学文献数据库(Medline)、科学网数据库、文献人工检索及专家文献目录来确定潜在的研究。纳入的研究需报告:(a)体重测量值;(b)食管或贲门腺癌诊断的发生情况;(c)相对风险或比值比(OR)及置信区间(CI),或提供足够数据以进行计算。
我们确定了14项研究(2项队列研究,12项病例对照研究;2488例食管腺癌和2509例贲门腺癌)。高BMI(>25)与食管腺癌风险增加相关(男性,OR为2.2;95%CI为1.7 - 2.7;女性,OR为2.0;95%CI为1.4 - 2.9)。较高的BMI水平与风险增加相关(超重男性,OR为1.8;95%CI为1.5 - 2.2;肥胖男性,OR为2.4;95%CI为1.9 - 3.2)。与贲门癌的总体关联存在异质性,尽管按研究地点分层后,美国或欧洲人群的结果具有同质性。高BMI与贲门腺癌风险呈弱相关(OR为1.5;95%CI为1.3 - 1.8;P(异质性)=0.38)。
观察性研究的汇总结果支持高BMI与食管腺癌以及可能与贲门腺癌风险之间存在正相关。